Carson Allaria Wealth Management, Ltd. Moderna, Inc. Transaction History
Carson Allaria Wealth Management, Ltd.
- $169 Million
- Q4 2024
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 196 shares of MRNA stock, worth $6,587. This represents 0.0% of its overall portfolio holdings.
Number of Shares
196
Previous 112
75.0%
Holding current value
$6,587
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding MRNA
# of Institutions
908Shares Held
235MCall Options Held
10.6MPut Options Held
18.7M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.35 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.31 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$859 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$566 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$243 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...